DNYUZ
No Result
View All Result
DNYUZ
No Result
View All Result
DNYUZ
Home News

White House weighs next steps for FDA nominee who faces bipartisan pushback

November 16, 2026
in News
White House weighs next steps for FDA nominee who has faced MAHA, vaccine doubts

Some Trump administration officials are growing skeptical that the Senate will confirm Heidi Overton to lead the Food and Drug Administration, prompting them to discuss whether to attempt to shore up her nomination or abandon it altogether, according to four people familiar with the matter who spoke on the condition of anonymity to discuss a personnel matter.

Overton, who serves as the deputy director of the White House’s Domestic Policy Council, has been intricately involved in President Donald Trump’s health agenda. But her nomination has faced an uphill battle as some Republicans, many Democrats and prominent supporters of Health Secretary Robert F. Kennedy Jr.’s Make America Healthy Again movement have questioned or opposed her candidacy.

Sen. Bill Cassidy (R-Louisiana), who chairs the Senate health panel slated to hold a vote Wednesday on Overton, said Sunday on CBS’s “Face the Nation” that he still had “questions” about her fitness to serve.

“I cannot tell you the outcome of that vote right now,” he said. Cassidy, a trained physician who helped secure Kennedy’s nomination, has since expressed misgivings about Kennedy and Trump’s efforts to remake vaccine policy. He also pressed Overton extensively on vaccines during a September hearing.

Cassidy told CBS that he was wrestling with the trade-off of relying on temporary FDA chiefs versus the Senate confirming a commissioner who might not be “the perfect candidate” but could have “some independence” in the role.

Federal officials have started discussing potential alternative candidates, according to two people familiar with the matter.

The White House did not immediately comment. On social media, a White House account posted Monday a column from the former dean of the University of New Mexico School of Medicine who said he has known Overton since the early days of her training and urged the Senate to confirm her.

Trump has previously pulled several nominations for top health positions, including his first pick to lead the Centers for Disease Control and Prevention and two of his picks to serve as U.S. surgeon general.

Republicans currently hold a one-seat majority on the Cassidy-led Health, Education, Labor and Pensions Committee, meaning that if all Democrats vote against Overton’s nomination, a single GOP defection could effectively end her candidacy. GOP leaders could still attempt to take her nomination directly to the Senate floor but would probably face procedural and political obstacles.

Democrats are set to retake the Senate majority in January, complicating the path for Trump to advance his nominees.

Influential MAHA advocates have been angry over the president’s decision to nominate Overton. They have argued she is not a disrupter who will challenge corporate interests, and her nomination has also served as a proxy battle over glyphosate, a commonly used weed killer.

Some MAHA activists point to an executive order that boosted the production of the herbicide they say causes harm to children. Calley Means, a former White House adviser, has alleged that Overton worked with the Department of Justice to “construct a legal argument” for why the Supreme Court should take up a case that restricted a massive wave of lawsuits against a chemical giant and did not consult Kennedy. Means also alleged that she wrote the policy to relax standards on fruit-flavored vapes.

The White House did not immediately comment on the allegations. Kush Desai, a former White House spokesman who is still working in the administration, has previously said that Overton “pushed as many MAHA-minded edits as possible to a mostly-baked EO that, again, was written with national security considerations in mind.”

During her Senate confirmation hearing, Overton said that “there is a 100% agreement from this administration that we must protect kids from illegal substances and from vapes and from flavored vapes.” She added that the agency must follow rules weighing whether a product is appropriate for the protection of public health and that adults are using flavors to help them quit smoking.

Some White House officials previously argued that Overton’s job as a domestic policy aide is to help vet proposals and ensure they are legally sound, and not necessarily based on her personal preferences. When Trump nominated Overton in August, he referred to her as “a ROCKSTAR in my Administration.”

A new campaign launched Friday painting Overton as “Heidi Vaperton” — depicting her holding a vape in posters and yard signs going up across D.C. and other cities — and urging senators to “say no” to her candidacy. The signs are the work of a group dubbed “Health in Office,” said their spokeswoman, Jennifer Kay, who declined to share the activists’ identities but said they were “nonpartisan” and worried about Trump’s health agenda.

Spotted in DC today: new “Heidi Vaperton” signs, attacking Trump’s FDA pick, Heidi Overton pic.twitter.com/vGfvS0SLY5

— Dan Diamond (@ddiamond) November 14, 2026

“They are a group of private citizens who deeply care about this issue,” Kay told The Washington Post in an interview, adding that signs were also going up in Alaska, Louisiana and Maine — targeting Senate Republicans Lisa Murkowski (Alaska), Cassidy and Susan Collins (Maine), all of whom have expressed misgivings about some of Trump’s health policies.

The permanent position of FDA commissioner has been vacant since Marty Makary resigned in May after he had incurred the frustration of White House officials, while his allies have characterized his departure as a matter of principle, saying he was unhappy about allowing the sale of fruit-flavored vapes. Kyle Diamantas, who was previously the agency’s top food official and a senior counselor to Kennedy, has been serving as acting FDA chief.

Over the summer, Overton stood by Trump as he announced a sweeping executive order aimed at reducing the number of immunizations recommended for children, breaking up the measles, mumps and rubella shot, and spacing out vaccinations. She called the action “historic,” prompting backlash from Cassidy.

During her hearing, Cassidy repeatedly quizzed her on vaccines. Overton said that the combined MMR shot was “not lethal” and was “safe and effective,” which stands in contrast to remarks Trump made saying that taken “together there could be a possibility they’re quite lethal.”

Overton, a physician who is board-certified in public health and general preventive medicine and worked with Makary at Johns Hopkins, has maintained a low public profile compared with him and some of Trump’s other top health officials, such as former FDA commissioner Scott Gottlieb, who have been frequent commentators in the media.

Gottlieb endorsed Overton to lead the FDA in a September op-ed in Stat News published with Mark McClellan, another former Republican FDA commissioner.

The post White House weighs next steps for FDA nominee who faces bipartisan pushback appeared first on Washington Post.

Mamdani’s Move to Disband N.Y.P.D. Unit Provokes Praise, Anger and Spin
News

Mamdani’s Move to Disband N.Y.P.D. Unit Provokes Praise, Anger and Spin

by New York Times
November 16, 2026

At 6:59 a.m. on Monday, Mayor Zohran Mamdani released a social media video to announce that he was disbanding the ...

Read more
News

Devin Hester says chasing rabbits through Florida sugarcane fields helped build NFL speed

November 16, 2026
News

SNL’s ‘Sister’ sketch captures the hidden burden of caring for aging parents

November 16, 2026
News

LA sheriff cuts ties with charity run by top NY tax dodger Daniel Gordon — after Post exposes his criminal past

November 16, 2026
News

How not to prevent U.S. adversaries from getting the AI goods

November 16, 2026
Richard Sterban, Oak Ridge Boys bass singer who put the ‘oom-papa-mow-mow’ in ‘Elvira,’ dies at 83

Richard Sterban, Oak Ridge Boys bass singer who put the ‘oom-papa-mow-mow’ in ‘Elvira,’ dies at 83

November 16, 2026
White House weighs next steps for FDA nominee who has faced MAHA, vaccine doubts

White House weighs next steps for FDA nominee who faces bipartisan pushback

November 16, 2026
LACMA’s Art+Film Gala Fashion Was Daring, Dazzling — and Sometimes Barely There

LACMA’s Art+Film Gala Fashion Was Daring, Dazzling — and Sometimes Barely There

November 16, 2026

DNYUZ © 2026

No Result
View All Result

DNYUZ © 2026